Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of...
Transcript of Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of...
![Page 1: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/1.jpg)
Challenging Bilateral Iliac Occlusions
Mr. Hany Zayed MD, MSc, FRCS
Consultant Vascular Surgeon
Guy’s and St. Thomas’ NHS Foundation Trust
![Page 2: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/2.jpg)
Disclosure
Speaker name:
.................................................................................
I have the following potential conflicts of interest to report:
Consulting
Employment in industry
Stockholder of a healthcare company
Owner of a healthcare company
✓ Other(s)
I do not have any potential conflict of interest
![Page 3: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/3.jpg)
![Page 4: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/4.jpg)
![Page 5: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/5.jpg)
![Page 6: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/6.jpg)
![Page 7: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/7.jpg)
![Page 8: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/8.jpg)
![Page 9: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/9.jpg)
![Page 10: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/10.jpg)
![Page 11: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/11.jpg)
![Page 12: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/12.jpg)
• 74 Yrs
• Cardiovascular Risk Factors:
IHD, Coronary stenting
Pacemaker
HTN
Hyperchol.
• Life-limiting Intermittent Claudication:
Sole carer of Wheelchair-bound wife.
• Best medical treatment
• Completed SET
![Page 13: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/13.jpg)
![Page 14: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/14.jpg)
Revascularisation Plan
• Right Femoral endarterectomy + Access
• Left Brachial Percutaneous Access:
Imaging
Antegrade recanalisation if Retrograde approach fails
• Left Femoral Percutaneous Access
![Page 15: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/15.jpg)
![Page 16: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/16.jpg)
![Page 17: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/17.jpg)
![Page 18: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/18.jpg)
![Page 19: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/19.jpg)
![Page 20: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/20.jpg)
![Page 21: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/21.jpg)
![Page 22: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/22.jpg)
Which Covered-Stent to use ?
![Page 23: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/23.jpg)
![Page 24: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/24.jpg)
![Page 25: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/25.jpg)
![Page 26: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/26.jpg)
Conclusion
• VBX is a useful addition to the endovascular armamentarium.
• Potential solution to challenging Aorto-Iliac occlusive disease.
![Page 27: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/27.jpg)
Thank You
![Page 28: Challenging Bilateral Iliac Occlusions · Il C/D leslons. The prtmarr endpoint was a composite of device- or procedure-related death w'thln 30 days. myocardial hfarctlon wlthln 30](https://reader031.fdocuments.in/reader031/viewer/2022011904/5f1ff42f090d1854f9028387/html5/thumbnails/28.jpg)
Challenging Bilateral Iliac Occlusions
Mr. Hany Zayed MD, MSc, FRCS
Consultant Vascular Surgeon
Guy’s and St. Thomas’ NHS Foundation Trust